The prevalence of gastrointestinal diseases in israeli adolescents and its association with body mass index, gender, and jewish ethnicity

Journal of Clinical Gastroenterology

Volumn 42, Issue 8, 2008, Pages 903-909

  Landau, Dan Avi ^a   Goldberg, Avishy ^b   Levi, Zohar ^c   Levy, Yehezkel ^d   Niv, Yaron ^c   Bar Dayan, Yosefa ^b,e  

^a ISRAELI AIR FORCE   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Surgeon General Headquarters ^*  (Israel)

^e MEDICAL CORPS   (Israel)

Author keywords

Celiac disease; Cholelithiasis, adolescent; Epidemiology; Familial adenomatous polyposis; Gastro esophageal reflux disease; Inflammatory bowel disease; Irritable bowel syndrome; Pancreatitis; Peptic ulcer disease

Indexed keywords

ADENOMATOUS POLYP; ADOLESCENT; ANAMNESIS; ARMY; ARTICLE; BILE DUCT DISEASE; BODY MASS; CELIAC DISEASE; DISEASE ASSOCIATION; DYSPEPSIA; ENTERITIS; ETHNIC DIFFERENCE; FEMALE; GALLBLADDER DISEASE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GENDER; GENERAL PRACTITIONER; HUMAN; IRRITABLE COLON; ISRAEL; JEW; LACTASE DEFICIENCY; LACTOSE INTOLERANCE; MAJOR CLINICAL STUDY; MALE; PANCREAS DISEASE; PEPTIC ULCER; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SEX DIFFERENCE; TIME SERIES ANALYSIS; ETHNOLOGY; SOLDIER;

ADOLESCENT; BODY MASS INDEX; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; ISRAEL; JEWS; MALE; MILITARY PERSONNEL; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 54549103228     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31814685f9     Document Type: Article

References (63)

1. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500-1511.
2. Ehlin AG, Montgomery SM, Ekbom A, et al. Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut. 2003;52:1117-1121.
3. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142:76-83.
4. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984;29: 913-920.
5. Patten SB, Li FX, Cook T, et al. Irritable bowel syndrome: are incentives useful for improving survey response rates? J Clin Epidemiol. 2003;56:256-261.
6. Muller-Lissner SA, Bollani S, Brummer RJ, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion. 2001;64:200-204.
7. Sperber AD, Shvartzman P, Friger M, et al. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil. 2005;17:207-211.
8. El Mouzan MI, Abdullah AM. Peptic ulcer disease in children and adolescents. J Trop Pediatr. 2004;50:328-330.
9. Bar Dayan Y, Elishkevits K, Grotto I, et al. The prevalence of obesity and associated morbidity among 17-year-old Israeli conscripts. Public Health. 2005;119:385-389.
10. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.
11. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290: 66-72.
12. Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 1999;94:2961-2965.
13. Niv Y, Torten D, Tamir A, et al. Incidence and prevalence of ulcerative colitis in the upper Galilee, Northern Israel, 1967-1986. Am J Gastroenterol. 1990;85:1580-1583.
14. Odes HS, Krawiec J, Weitzman S. Prevalence of Crohn's disease in Israel. N Engl J Med. 1982;306:750-751.
15. Odes HS, Fraser D, Krawiec J. Inflammatory bowel disease in migrant and native Jewish populations of southern Israel. Scand J Gastroenterol Suppl. 1989;170:36-38. Discussion 50-55.
16. Grossman A, Fireman Z, Lilos P, et al. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970-1980. Hepatogastroenterology. 1989;36:193-197.
17. Fireman Z, Grossman A, Lilos P, et al. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. Am J Gastroenterol. 1989;84:255-258.
18. Birkenfeld S, Keter D, Dikman R, et al. Prevalence of Helicobacter pylori infection in health-care personnel of primary care and gastroenterology clinics. J Clin Gastroenterol. 2004;38:19-23.
19. Niv Y, Abuksis G, Koren R. 13C-urea breath test, referral patterns, and results in children. J Clin Gastroenterol. 2003;37:142-146.
20. Kahrilas PJ, Pandolfino JE. Gastroesophageal reflux disease and its complications including Barrett's esophagus. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002:607.
21. McQuaid KR. Dyspepsia. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002:102-112.
22. Spechler SJ. Peptic ulcer and its complications. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Suanders; 2002:756-758.
23. Hogenauer C, Hammer HF. Maldigestion and malabsorption. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002:1768.
24. Farrell RJ, Kelly CP. Celiac sprue and refractory sprue. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders; 2002:1817-1830.
25. Sands BE. Crohn's disease. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002: 2005-2017.
26. Jewell D. Ulcerative colitis. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002: 2039-2052.
27. Thompson WG. Irritable bowel syndrome: pathogenesis and management. Lancet. 1993;341:1569-1572.
28. Itzkowitz SH. Colonic polyps and polyposis syndromes. In: Feld-man M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002:2198.
29. Drumm B, Rhoads JM, Stringer DA, et al. Peptic ulcer disease in children: etiology, clinical findings, and clinical course. Pediatrics. 1988;82:410-414.
30. Blecker U, Gold BD. Gastritis and peptic ulcer disease in childhood. Eur J Pediatr. 1999;158:541-546.
31. Gdalevich M, Cohen D, Ashkenazi I, et al. Helicobacter pylori infection and subsequent peptic duodenal disease among young adults. Int J Epidemiol. 2000;29:592-595.
32. Chan KL, Tam PK, Saing H. Long-term follow-up of childhood duodenal ulcers. J Pediatr Surg. 1997;32:1609-1611.
33. Goldbourt U, Medalie JH. Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol. 1977;105: 75-86.
34. Menachem Y, Odes HS, Neumann L, et al. Demographic data from a hospital case series of endoscopically-diagnosed benign peptic ulcer in southern Israel, 1989-1990. Public Health Rev. 1995;23: 47-58.
35. Baretic M, Bilic A, Jurcic D, et al. Epidemiology of irritable bowel syndrome in Croatia. Coll Antropol. 2002;26(suppl):85-91.
36. Simren M, Mansson A, Langkilde AM, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001;63:108-115.
37. Hunt RH. Evolving concepts in the pathophysiology of functional gastrointestinal disorder. J Clin Gastroenterol. 2002;35:S2-S6.
38. Knill-Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol Suppl. 1991;182:17-24.
39. Maconi G, Tosetti C, Stanghellini V, et al. Dyspeptic symptoms in primary care. An observational study in general practice. Eur J Gastroenterol Hepatol. 2002;14:985-990.
40. Sood MR, Rudolph CD. Gastroesophageal reflux in adolescents. Adolesc Med Clin. 2004;15:17-36, vii-viii.
41. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med. 2000;154:150-154.
42. Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517-524.
43. Lynch HT, Brand RE, Locker GY. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer. Fam Cancer. 2004;3:229-232.
44. Shapira M, Tamir A. Crohn's disease and the Jews. J Clin Gastroenterol. 1992;15:278-280.
45. Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol. 1992;27: 609-614.
46. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol. 2000;12:31-38.
47. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut. 1989;30: 618-622.
48. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001;357:1093-1094.
49. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol. 2001;13:1439-1447.
50. Dahan S, Slater PE, Cooper M, et al. Coeliac disease in the Rehovot-Ashdod region of Israel: incidence and ethnic distribution. J Epidemiol Community Health. 1984;38:58-60.
51. Catassi C, Ratsch IM, Fabiani E, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994;343:200-203.
52. Catassi C, Fabiani E, Ratsch IM, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 1996;412:29-35.
53. Kang JY, Ellis C, Majeed A, et al. Gallstones - an increasing problem: a study of hospital admissions in England between 1989/ 1990 and 1999/2000. Aliment Pharmacol Ther. 2003;17:561-569.
54. Bailey PV, Connors RH, Tracy TF Jr, et al. Changing spectrum of cholelithiasis and cholecystitis in infants and children. Am J Surg. 1989;158:585-588.
55. Grosfeld JL, Rescorla FJ, Skinner MA, et al. The spectrum of biliary tract disorders in infants and children. Experience with 300 cases. Arch Surg. 1994;129:513-518. Discussion 518-520.
56. Miltenburg DM, Schaffer R III, Breslin T, et al. Changing indications for pediatric cholecystectomy. Pediatrics. 2000;105:1250-1253.
57. Takiff H, Fonkalsrud EW. Gallbladder disease in childhood. Am J Dis Child. 1984;138:565-568.
58. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics. 2002;109:E81-1.
59. Ganesh R, Muralinath S, Sankaranarayanan VS, et al. Prevalence of cholelithiasis in children - a hospital-based observation. Indian J Gastroenterol. 2005;24:85.
60. Rozen P, Samuel Z, Rabau M, et al. Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features. Fam Cancer. 2001;1:75-82.
61. Bulow S. Results of national registration of familial adenomatous polyposis. Gut. 2003;52:742-746.
62. Bjork J, Akerbrant H, Iselius L, et al. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. Scand J Gastro-enterol. 1999;34:1230-1235.
63. Jarvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut. 1992;33:357-360.